BackCaribou Biosciences Overview

Caribou Biosciences Total Liabilities

Latest total liabilities for CRBU: $47M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$46.98M
16.75% YoYΔ $-9.45M vs prior year quarter

Peer average

Loading

Caribou Biosciences Total Liabilities History

Loading

Caribou Biosciences vs. peers: Total Liabilities Comparison

Loading

Caribou Biosciences Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Caribou Biosciences (CRBU) FAQ

As of the most recent data (March 2026), CRBU shows a total liabilities of $47M. That compares with $56M in the prior-year period — down 16.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CRBU's total liabilities is now $47M (was $56M) — a 16.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Caribou Biosciences is outperforming or lagging.

Tracking CRBU's total liabilities over time shows whether Caribou Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $47M That compares with $56M in the prior-year period — down 16.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Caribou Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $47M) with ownership activity and broader fundamentals.

Caribou Biosciences's total liabilities is $47M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.